RTVA

AI-Driven Real Time Voice Analyzer COVID Screening App Hits Major Milestone of 100,000 Installs in Just Seven Weeks

Retrieved on: 
Friday, February 2, 2024
Partnership, COVID-19, HIPAA, Research, Google Play, Language, University of Cambridge, COVID, CDC, Apple Store, Massachusetts Institute of Technology, Real-time, Smartphone, Carnegie Mellon University, Algorithm, Doctor of Philosophy, University, Health, RTVA, Human, Mobile phone

CABOT, Ark., Feb. 2, 2024 /PRNewswire-PRWeb/ -- RTVA, Inc. and Hematico, LLC, developers of Real Time Voice Analyzer (RTVA) - the first mobile health app to non-invasively screen for COVID and other respiratory health anomalies, announced today the app hit 100,000 installs in just seven weeks. The app is powered by patent-pending AI technology developed by Carnegie Mellon University professor Rita Singh, PhD, an expert in the field of voice analysis research and respiratory illness detection. Dr. Singh has more than 25 years of experience and research in voice analysis. The University of Cambridge and Massachusetts Institute of Technology have complied similar studies. The AI-driven RTVA app is revolutionizing COVID screening and experiencing a surge in popularity with users.

Key Points: 
  • CABOT, Ark., Feb. 2, 2024 /PRNewswire-PRWeb/ -- RTVA, Inc. and Hematico, LLC, developers of Real Time Voice Analyzer (RTVA) - the first mobile health app to non-invasively screen for COVID and other respiratory health anomalies, announced today the app hit 100,000 installs in just seven weeks.
  • Dr. Singh has more than 25 years of experience and research in voice analysis.
  • The AI-driven RTVA app is revolutionizing COVID screening and experiencing a surge in popularity with users.
  • RTVA delivers a fast, accurate, and non-invasive COVID or respiratory illness screening without uncomfortable nasal swabs or painful tests.

Real Time Voice Analyzer is a New Mobile Health App Revolutionizing COVID Screening Using Advanced AI to Non-Invasively Detect Respiratory Viruses with Voice Biomarkers

Retrieved on: 
Monday, October 16, 2023
Algorithm, Language, Partnership, COVID-19, Massachusetts Institute of Technology, Doctor of Philosophy, Analyser, Human, COVID, Real-time, AI, MD, Carnegie Mellon University, Smartphone, CDC, University, RTVA, University of Cambridge, Research, Mobile phone, Medical device, Vaccine, Online shopping

CABOT, Ark., Oct. 16, 2023 /PRNewswire-PRWeb/ -- A new mobile health app is revolutionizing COVID screening and changing respiratory health. The Real Time Voice Analyzer (RTVA) is the first non-invasive COVID screening tool powered by patent-pending AI technology. Check out the video here - https://www.youtube.com/watch?v=I2K43tejy1M

Key Points: 
  • CABOT, Ark., Oct. 16, 2023 /PRNewswire-PRWeb/ -- A new mobile health app is revolutionizing COVID screening and changing respiratory health.
  • The Real Time Voice Analyzer (RTVA) is the first non-invasive COVID screening tool powered by patent-pending AI technology.
  • The Real Time Voice Analyzer mobile health app lets anyone get a fast, accurate, and non-invasive COVID or respiratory illness screening in just five minutes, anywhere and anytime, without uncomfortable nasal swabs or painful tests.
  • Uses only the sound of a person's voice, like a doctor using a stethoscope to detect irregularities in vital organs.